AVE 20.0% 0.3¢ avecho biotechnology limited

Good points made by all. We have all assumed that the Elixia...

  1. 5,322 Posts.
    Good points made by all. We have all assumed that the Elixia revenues are available to fund Oxy. Playez has made the point that Elixia revenues are needed to fund growth of Elixia. Well depending on the terms that POH has negotiated with Sungate Asia and it's plans for a near term launch into the USA..he may just be on the mark. The rapid expansion may well require the reinvestment of Elixia revenues into manufacturing and marketing of Elixia and BioElixia. I don't believe anyone here predicted how successful personal care would be for POH or how fast this division would grow into a Global brand. Since no one posting has any idea of what POHs plans for funding are I think it appropriate that POH update the market before they commence the Oxy Trials . It really is all that is holding back the sp. I don't mind whatever path they have locked into as it will have been carefully considered and planned by the board and our corporate advisors ....but just tell us sooner than later
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(20.0%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $33 10.94K

Buyers (Bids)

No. Vol. Price($)
62 99962608 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 53831289 11
View Market Depth
Last trade - 13.14pm 17/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.